Key result
Surgical therapy for intertrochanteric fractures is linked to ~66% lower mortality versus conservative therapy.
Why the study?
Intertrochanteric fractures are expected to rise with the growing elderly population, but data assessing excess mortality and predictors of long-term mortality by therapy were needed.
Does surgical therapy reduce mortality compared to conservative therapy in patients aged 50 years and older with intertrochanteric fractures?
Population
3029 patients aged 50 years and older with an intertrochanteric fracture in Tianjin
Comparison
Surgical therapy vs conservative therapy
Design
Retrospective cohort study
Follow-up
Until March 31, 2022
Authors
Loading...
May support surgical consideration in eligible patients ≥50 years; leaves open causal benefit versus confounding in observational data.
Cohort (n=3,029)
Does surgical therapy reduce mortality compared to conservative therapy in patients aged 50 years and older with intertrochanteric fractures?
Hazard Ratio: 0.34 (95% CI 0.23–0.52)
Absolute Event Rate: 12.07% vs 43.04%
p-value: p=0.000
Surgical therapy significantly reduces mortality compared to conservative therapy in patients aged 50 years and older with intertrochanteric fractures.
Cui et al. (2023) conducted a cohort in Intertrochanteric fracture (n=3,029). Surgical therapy vs. Conservative therapy was evaluated on Mortality (HR 0.34, 95% CI 0.23-0.52, p=0.000). Surgical therapy for intertrochanteric fractures in patients aged ≥50 years was associated with substantially lower mortality compared to conservative therapy (HR 0.34; 95% CI 0.23-0.52; p=0.000).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: